B of A Securities Maintains Neutral on Editas Medicine, Lowers Price Target to $15
B of A Securities analyst Greg Harrison maintains Editas Medicine (NASDAQ:EDIT) with a Neutral and lowers the price target from $18 to $15.
Truist Securities Maintains Buy on Editas Medicine, Lowers Price Target to $35
Truist Securities analyst Joon Lee maintains Editas Medicine (NASDAQ:EDIT) with a Buy and lowers the price target from $80 to $35.
Morgan Stanley Maintains Underweight on Editas Medicine, Lowers Price Target to $8
Morgan Stanley analyst Matthew Harrison maintains Editas Medicine (NASDAQ:EDIT) with a Underweight and lowers the price target from $10 to $8.
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Oppenheimer Downgrades Editas Medicine to Perform, Lowers Price Target to $12
Oppenheimer analyst Jay Olson downgrades Editas Medicine (NASDAQ:EDIT) from Outperform to Perform and lowers the price target from $28 to $12.
Nasdaq Down 60 Points; Alibaba Posts Upbeat Q2 Earnings
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 60 points on Thursday.
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.
Citing Small Population, Editas Medicine Pauses Work On Gene Therapy Trial For Genetic Eye Disorder
Editas Medicine Inc (NASDAQ:EDIT) announced clinical data from the Phase 1/2 BRILLIANCE trial of EDIT-101, an in vivo CRISPR/Cas9 genome editing medicine. EDIT-101…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Ardelyx (NASDAQ:ARDX) shares moved upwards by 53.3% to $1.87 during Thursday’s regular session. Trading volume for Ardelyx’s…
S&P 500 Down 1%; Crude Oil Drops Sharply
U.S. stocks traded lower midway through trading, with the S&P 500 dropping around 1% on Thursday.